Cathay Biotech Inc.
688065.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | CN¥475 | CN¥367 | CN¥613 | CN¥647 |
| Dep. & Amort. | CN¥321 | CN¥286 | CN¥265 | CN¥169 |
| Deferred Tax | CN¥0 | -CN¥71 | -CN¥36 | -CN¥17 |
| Stock-Based Comp. | CN¥0 | CN¥0 | CN¥16 | CN¥6 |
| Change in WC | -CN¥27 | -CN¥233 | -CN¥74 | -CN¥212 |
| Other Non-Cash | CN¥52 | CN¥221 | CN¥20 | CN¥2 |
| Operating Cash Flow | CN¥821 | CN¥569 | CN¥804 | CN¥594 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -CN¥843 | -CN¥1,570 | -CN¥4,198 | -CN¥1,475 |
| Net Acquisitions | CN¥0 | CN¥0 | CN¥6 | CN¥1,850 |
| Inv. Purchases | CN¥0 | -CN¥101 | CN¥0 | -CN¥1,850 |
| Inv. Sales/Matur. | CN¥0 | CN¥0 | CN¥0 | CN¥28 |
| Other Inv. Act. | CN¥20 | CN¥112 | -CN¥6 | CN¥1,320 |
| Investing Cash Flow | -CN¥823 | -CN¥1,559 | -CN¥4,198 | -CN¥126 |
| Financing Activities | – | – | – | – |
| Debt Repay. | CN¥123 | CN¥647 | CN¥386 | CN¥743 |
| Stock Issued | CN¥0 | CN¥0 | CN¥95 | CN¥0 |
| Stock Repurch. | -CN¥29 | -CN¥32 | -CN¥95 | CN¥0 |
| Dividends Paid | -CN¥141 | -CN¥105 | -CN¥187 | -CN¥333 |
| Other Fin. Act. | CN¥196 | -CN¥773 | CN¥224 | CN¥2,578 |
| Financing Cash Flow | CN¥149 | -CN¥262 | CN¥404 | CN¥2,987 |
| Forex Effect | CN¥25 | CN¥40 | CN¥60 | -CN¥9 |
| Net Chg. in Cash | CN¥172 | -CN¥1,211 | -CN¥2,931 | CN¥3,446 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | CN¥5,014 | CN¥6,225 | CN¥9,156 | CN¥5,710 |
| End Cash | CN¥5,186 | CN¥5,014 | CN¥6,225 | CN¥9,156 |
| Free Cash Flow | -CN¥22 | -CN¥1,000 | -CN¥3,395 | -CN¥880 |